Effects of Repeated Intravenous Anesthesia With Propofol on the Postoperative Neurological Function of Patients Undergoing Hysteroscopic Surgery
NCT ID: NCT05297682
Last Updated: 2022-05-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
258 participants
OBSERVATIONAL
2022-04-01
2024-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Propofol Versus Sevoflurane Recovery After Gynecological Surgery
NCT01755234
Comparison of Sevoflurane, Propofol, and Sevoflurane Plus Propofol for Maintenance of Anaesthesia
NCT01084200
EP Intravenous Anesthesia in Hysteroscopy
NCT05259787
Sevoflurane With or Without Intravenous Lidocaine Infusion Versus Propofol Anesthesia on Intracranial Pressure and Cerebral Oxygenation During Laparoscopic Hysterectomy
NCT07062367
Timing of Rocuronium After Induction With Propofol on Temporal Summation of Pain
NCT04547608
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Propofol and central nervous system dysfunction during perioperative period Perioperative neurocognitive disorders (PND) include neurocognitive disorders, sleep disorders, and anxiety and depression. The incidence rate is as high as 15%-78%, which affects the rehabilitation and quality of life of patients. A large number of studies have shown that a single anesthesia operation has a slight and short-term impact on the patient's neurological function. However, the impact of multiple anesthesia operations on the patient's neurological function is currently unclear.
Propofol was marketed in the UK in 1986, and was approved in the United States in 1989. It was approved for clinical use in my country in 1994, becoming a widely used clinical general anesthesia induction and maintenance drug. Animal experiments have found that a single exposure of propofol can cause transient neuronal apoptosis and defects in rats, while multiple exposures of propofol can lead to sustained neuronal apoptosis, neuronal defects, synaptic loss, and long-term Cognitive impairment. Repeated exposure to propofol in the neonatal period of rats can damage hippocampal synaptic plasticity and decline in cognitive function in adulthood. Repeated use of propofol can activate the NF-κB pathway and NLRP3 inflammasome, up-regulate the RAGE protein and other pathways, causing hippocampal inflammation and neuronal apoptosis, thereby impairing the cognitive function of elderly rats. The results of these animal studies suggest that repeated and multiple anesthesia operations can lead to neurological disorders. Clinical studies have reported that after a single propofol anesthesia in elderly patients undergoing laparoscopic surgery, 16.8%-18% of patients developed postoperative cognitive dysfunction 7 days after surgery; but whether repeated propofol anesthesia affects the patient's There is no research report on nerve function.
Intrauterine adhesions and transcervical resection of adhesion The infertility rate in China is currently as high as 12.5%-15%, and the number of patients exceeds 50 million, that is, 1 in every 8 couples has infertility problems. intrauterine adhesions (IUA) is a common gynecological uterine disease that seriously harms fertility and has poor treatment effects. It has become the main cause of secondary infertility in Chinese women. Transcervical resection of adhesion (TCRA) is the first choice for infertile women with fertility requirements to treat IUA. However, a large number of literature reports that the re-adhesion rate after TCRA is 30% in mild to moderate IUA, and as high as 62.5% in severe IUA, and the pregnancy success rate is only 22.5%-33.3%. Therefore, due to infertility, many women undergo repeated hysteroscopic surgery under general anesthesia in a short period of time, and some patients have undergone more than 10 anesthesia operations in just 2 years.
With the liberalization of China's plans to formulate policies, the number of patients with secondary infertility who have clinical needs continues to increase. Doctors have always paid more attention to the effect of increasing the uterine cavity of infertile patients, and the story of the neuronal function that may exist in such patients. Therefore, the change describes the clinical treatment plan for the actual infertility patients who have received general anesthesia and hysteroscopic surgery for many times. It is of great significance to social and economic development.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
singal group
Patients receiving less than two anesthesia in a year
anesthesia with propofol
General anesthesia with propofol
repeat group
Patients who received two or more anesthesia in a year
anesthesia with propofol
General anesthesia with propofol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
anesthesia with propofol
General anesthesia with propofol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Need hysteroscopic surgery due to intrauterine adhesions
* Women of childbearing age who wish to have children
Exclusion Criteria
* Those who are known or suspected to be allergic or contraindicated to propofol injection excipients
* Patients with acute upper respiratory tract infection, asthma attack, or acute severe laryngeal disease
* History of gastrointestinal disease: gastrointestinal retention, active bleeding, which may lead to reflux aspiration, etc.
* Complicated medical history of craniocerebral injury, intracranial hypertension, stroke, cerebrovascular accident
* Respiratory insufficiency, obstructive pulmonary disease
* Uncontrolled hypertension, hypotension, and diabetes
* Severe arrhythmia, heart failure, unstable angina, myocardial infarction
* Severe liver dysfunction or severe renal insufficiency
* History of alcoholism or drug dependence
* Abuse or long-term use of narcotic, sedative, and analgesic drugs
* Those who have a history of mental illness
* Participated in any other clinical investigators within 1 month before screening
* Subjects who are considered by the investigator to have any other factors that are not suitable for participating in this research
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Third Xiangya Hospital of Central South University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Qin Liao, M.D
Role: PRINCIPAL_INVESTIGATOR
The Third Xiangya Hospital, Central South University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Third Xiangya Hospital
Changsha, Hunan, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Belrose JC, Noppens RR. Anesthesiology and cognitive impairment: a narrative review of current clinical literature. BMC Anesthesiol. 2019 Dec 27;19(1):241. doi: 10.1186/s12871-019-0903-7.
Lee WL, Liu CH, Cheng M, Chang WH, Liu WM, Wang PH. Focus on the Primary Prevention of Intrauterine Adhesions: Current Concept and Vision. Int J Mol Sci. 2021 May 13;22(10):5175. doi: 10.3390/ijms22105175.
Tasbihgou SR, Absalom AR. Postoperative neurocognitive disorders. Korean J Anesthesiol. 2021 Feb;74(1):15-22. doi: 10.4097/kja.20294. Epub 2020 Jul 6.
Teng Y, Ou M, Wang X, Zhang W, Liu X, Liang Y, Li K, Wang Y, Ouyang W, Weng H, Li J, Yao S, Meng J, Shangguan W, Zuo Y, Zhu T, Liu B, Liu J. Efficacy and safety of ciprofol for the sedation/anesthesia in patients undergoing colonoscopy: Phase IIa and IIb multi-center clinical trials. Eur J Pharm Sci. 2021 Sep 1;164:105904. doi: 10.1016/j.ejps.2021.105904. Epub 2021 Jun 8.
Zhou Z, Zheng D, Wu H, Li R, Xu S, Kang Y, Cao Y, Chen X, Zhu Y, Xu S, Chen ZJ, Mol BW, Qiao J. Epidemiology of infertility in China: a population-based study. BJOG. 2018 Mar;125(4):432-441. doi: 10.1111/1471-0528.14966. Epub 2017 Dec 28.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Liaoqinzff
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.